Summarized by Masters of Longevity from Fight Aging!.
Stem cell therapy developments: an analytical review weighing why first-generation cell treatments faltered and what next-generation, cell-free directions may offer.
Key Takeaways
- Transplanted mesenchymal stem cells act mainly through short-lived paracrine signaling rather than long-term engraftment.
- Clinical outcomes for MSC therapies are highly variable due to source, donor, manufacturing, and disease microenvironment differences.
- The field is shifting toward engineered cell-free products such as MSC-derived extracellular vesicles and advanced bioengineering strategies.
